Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in ARDX — Ardelyx, Inc.

CIK 1037389 NEW YORK, NY
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,552,224
-$3,069,697 QoQ
Shares Held
892,593
-29.9% QoQ
Ownership
0.358%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 250 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. ARDX ranks #89 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in ARDX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,552,224 892,593
2026-03-31 $7,621,921 1,272,441
2025-12-31 $10,463,643 1,794,793
2025-09-30 $9,312,412 1,690,093
2025-06-30 $5,100,676 1,301,193
2025-03-31 $6,636,321 1,351,593
2023-09-30 $4,835,913 1,185,273
2023-06-30 $6,261,306 1,846,993
2023-03-31 $15,029,549 3,137,693
2022-12-31 $1,281,625 449,693
2022-09-30 $302,556 254,249
2022-06-30 $123,305 208,993
2022-03-31 $1,386,284 1,295,593
2021-12-31 $2,244,463 2,040,421
2021-03-31 $3,305,187 499,273
2020-12-31 $4,935,749 762,867
2020-09-30 $5,606,023 1,067,814
2020-06-30 $11,690,191 1,689,334
2020-03-31 $11,297,993 1,987,334